These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29316807)

  • 1. Cost-efficient designs for three-arm trials with treatment delivered by health professionals: Sample sizes for a combination of nested and crossed designs.
    Moerbeek M
    Clin Trials; 2018 Apr; 15(2):169-177. PubMed ID: 29316807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporating cost in power analysis for three-level cluster-randomized designs.
    Konstantopoulos S
    Eval Rev; 2009 Aug; 33(4):335-57. PubMed ID: 19509118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of complex, partially nested clustering in a three-arm individually randomized group treatment trial: A case study with the wHOPE trial.
    Tong G; Seal KH; Becker WC; Li F; Dziura JD; Peduzzi PN; Esserman DA
    Clin Trials; 2022 Feb; 19(1):3-13. PubMed ID: 34693748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Appropriate statistical methods for analysing partially nested randomised controlled trials with continuous outcomes: a simulation study.
    Candlish J; Teare MD; Dimairo M; Flight L; Mandefield L; Walters SJ
    BMC Med Res Methodol; 2018 Oct; 18(1):105. PubMed ID: 30314463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Best (but oft forgotten) practices: Efficient sample sizes for commonly used trial designs.
    Candel MJJM; van Breukelen GJP
    Am J Clin Nutr; 2023 Jun; 117(6):1063-1085. PubMed ID: 37270287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cluster randomized crossover trial: The effects of attrition in the AB/BA design and how to account for it in sample size calculations.
    Moerbeek M
    Clin Trials; 2020 Aug; 17(4):420-429. PubMed ID: 32191129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient design of cluster randomized and multicentre trials with unknown intraclass correlation.
    van Breukelen GJ; Candel MJ
    Stat Methods Med Res; 2015 Oct; 24(5):540-56. PubMed ID: 21937473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calculating sample sizes for cluster randomized trials: we can keep it simple and efficient!
    van Breukelen GJ; Candel MJ
    J Clin Epidemiol; 2012 Nov; 65(11):1212-8. PubMed ID: 23017638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Required sample size to detect mediation in 3-level implementation studies.
    Williams NJ; Preacher KJ; Allison PD; Mandell DS; Marcus SC
    Implement Sci; 2022 Oct; 17(1):66. PubMed ID: 36183090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sample size calculation for treatment effects in randomized trials with fixed cluster sizes and heterogeneous intraclass correlations and variances.
    Candel MJ; van Breukelen GJ
    Stat Methods Med Res; 2015 Oct; 24(5):557-73. PubMed ID: 25519890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal and maximin sample sizes for multicentre cost-effectiveness trials.
    Manju MA; Candel MJ; Berger MP
    Stat Methods Med Res; 2015 Oct; 24(5):513-39. PubMed ID: 25656551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient design of cluster randomized trials with treatment-dependent costs and treatment-dependent unknown variances.
    van Breukelen GJP; Candel MJJM
    Stat Med; 2018 Sep; 37(21):3027-3046. PubMed ID: 29888393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sample size determination for three-level randomized clinical trials with randomization at the first or second level.
    Fazzari MJ; Kim MY; Heo M
    J Biopharm Stat; 2014; 24(3):579-99. PubMed ID: 24697506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient treatment allocation in two-way nested designs.
    Lemme F; van Breukelen GJ; Berger MP
    Stat Methods Med Res; 2015 Oct; 24(5):494-512. PubMed ID: 24030312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sample size determinations for stepped-wedge clinical trials from a three-level data hierarchy perspective.
    Heo M; Kim N; Rinke ML; Wylie-Rosett J
    Stat Methods Med Res; 2018 Feb; 27(2):480-489. PubMed ID: 26988927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Power and sample size calculations for cluster randomized trials with binary outcomes when intracluster correlation coefficients vary by treatment arm.
    Kennedy-Shaffer L; Hughes MD
    Clin Trials; 2022 Feb; 19(1):42-51. PubMed ID: 34879711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maximin design of cluster randomized trials with heterogeneous costs and variances.
    van Breukelen GJP; Candel MJJM
    Biom J; 2021 Oct; 63(7):1444-1463. PubMed ID: 34247406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating Standardized Effect Sizes for Two- and Three-Level Partially Nested Data.
    Lai MH; Kwok OM
    Multivariate Behav Res; 2016; 51(6):740-756. PubMed ID: 27802077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.